The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 08, 2015

Filed:

Nov. 28, 2011
Applicants:

Paul F. Robbins, Potomac, MD (US);

Richard A. Morgan, Columbia, MD (US);

Steven A. Rosenberg, Potomac, MD (US);

Inventors:

Paul F. Robbins, Potomac, MD (US);

Richard A. Morgan, Columbia, MD (US);

Steven A. Rosenberg, Potomac, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/04 (2006.01); G01N 33/50 (2006.01); C07K 14/725 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
G01N 33/505 (2013.01); C07K 14/7051 (2013.01); G01N 33/5091 (2013.01); A61K 38/00 (2013.01);
Abstract

The invention is directed to a modified T cell receptor (TCR) comprising an amino acid sequence of a wild-type (WT) TCR with no more than three amino acid substitutions, wherein the modified TCR, as compared to the WT TCR, (i) has an enhanced ability to recognize target cells when expressed by CD4T cells and (ii) does not exhibit a decrease in antigen specificity when expressed by CD8T cells. Polypeptides, proteins, nucleic acids, recombinant expression vectors, host cells, populations of cells, antibodies, and pharmaceutical compositions related to the modified TCR also are part of the invention. Further, the invention is directed to methods of detecting a diseased cell in a host, methods of treating or preventing a disease in a host, and methods of identifying a candidate adoptive immunotherapy TCR.


Find Patent Forward Citations

Loading…